GTCR Recapitalizes PathGroup

May 13, 2022

GTCR has made a majority investment in PathGroup Holdings LLC in a recapitalization that leaves founder and CEO Dr. Ben Davis and the PathGroup management team substantially reinvested. Pritzker Private Capital and Vesey Street Capital Partners will retain minority stakes; the investment will fund geographic expansion (including into Texas), capability building across pathology, molecular and genetic diagnostics, and strategic M&A, and names Dave King as board chairman.

Buyers
GTCR
Targets
PathGroup Holdings LLC
Sellers
Pritzker Private Capital, Vesey Street Capital Partners
Location
Tennessee, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.